Prediction of future rheumatoid arthritis

Rheumatic Disease Clinics of North America

Volumn 40, Issue 4, 2014, Pages 753-770

  Turk, Samina A ^a   van Beers Tas, Marian H ^a   van Schaardenburg, Dirkjan ^a  

^a Reade Institute location Jan van Breemen   (Netherlands)

Author keywords

Arthralgia; Autoantibodies; Biomarkers; Environmental; Prediction; Rheumatoid arthritis; Risk factors

Indexed keywords

AUTOANTIBODY;

ARTHRALGIA; BIRTH WEIGHT; COMORBIDITY; DIABETES MELLITUS; ENVIRONMENTAL FACTOR; FAMILY HISTORY; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; OBESITY; PREDICTION; REVIEW; RHEUMATOID ARTHRITIS; ALCOHOL ABSTINENCE; ARTHRITIS, RHEUMATOID; FEMALE; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MALE; MASS SCREENING; REPRODUCTIVE HISTORY; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING; STATISTICS AND NUMERICAL DATA;

ALCOHOL ABSTINENCE; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIRTH WEIGHT; DIABETES MELLITUS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MASS SCREENING; OBESITY; REPRODUCTIVE HISTORY; RISK ASSESSMENT; SEX FACTORS; SMOKING;

EID: 84908060741     PISSN: 0889857X     EISSN: 15583163     Source Type: Journal    
DOI: 10.1016/j.rdc.2014.07.007     Document Type: Review

References (180)

1. Nielen M.M., van S.D., Reesink H.W., et al. Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis. Ann Rheum Dis 2006, 65(4):535-537.
2. van de Stadt L.A., de Koning M.H., van de Stadt R.J., et al. Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis. Arthritis Rheum 2011, 63(11):3226-3233.
3. Boers M., Verhoeven A.C., Markusse H.M., et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997, 350(9074):309-318.
4. Goekoop-Ruiterman Y.P., de Vries-Bouwstra J.K., Allaart C.F., et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 2008, 58(2 Suppl):S126-S135.
5. Aletaha D., Neogi T., Silman A.J., et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010, 69(9):1580-1588.
6. Britsemmer K., Ursum J., Gerritsen M., et al. Validation of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: slight improvement over the 1987 ACR criteria. Ann Rheum Dis 2011, 70(8):1468-1470.
7. Janowsky E.C., Kupper L.L., Hulka B.S. Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. NEngl J Med 2000, 342(11):781-790.
8. Perkins L.L., Clark B.D., Klein P.J., et al. Ameta-analysis of breast implants and connective tissue disease. Ann Plast Surg 1995, 35(6):561-570.
9. Wong O. Acritical assessment of the relationship between silicone breast implants and connective tissue diseases. Regul Toxicol Pharmacol 1996, 23(1 Pt 1):74-85.
10. Heliovaara M., Aho K., Knekt P., et al. Coffee consumption, rheumatoid factor, and the risk of rheumatoid arthritis. Ann Rheum Dis 2000, 59(8):631-635.
11. Karlson E.W., Mandl L.A., Aweh G.N., et al. Coffee consumption and risk of rheumatoid arthritis. Arthritis Rheum 2003, 48(11):3055-3060.
12. Mikuls T.R., Cerhan J.R., Criswell L.A., et al. Coffee, tea, and caffeine consumption and risk of rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 2002, 46(1):83-91.
13. Pedersen M., Jacobsen S., Klarlund M., et al. Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides. Arthritis Res Ther 2006, 8(4):R133.
14. Benito-Garcia E., Feskanich D., Hu F.B., et al. Protein, iron, and meat consumption and risk for rheumatoid arthritis: a prospective cohort study. Arthritis Res Ther 2007, 9(1):R16.
15. Grant W.B. The role of meat in the expression of rheumatoid arthritis. Br J Nutr 2000, 84(5):589-595.
16. Pattison D.J., Symmons D.P., Lunt M., et al. Dietary risk factors for the development of inflammatory polyarthritis: evidence for a role of high level of red meat consumption. Arthritis Rheum 2004, 50(12):3804-3812.
17. Alamanos Y., Voulgari P.V., Drosos A.A. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum 2006, 36(3):182-188.
18. Costenbader K.H., Chang S.C., Laden F., et al. Geographic variation in rheumatoid arthritis incidence among women in the United States. Arch Intern Med 2008, 168(15):1664-1670.
19. Kallberg H., Vieira V., Holmqvist M., et al. Regional differences regarding risk of developing rheumatoid arthritis in Stockholm County, Sweden: results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis (EIRA) study. Scand J Rheumatol 2013, 42(5):337-343.
20. Li X., Sundquist J., Sundquist K. Risks of rheumatic diseases in first- and second-generation immigrants in Sweden: a nationwide followup study. Arthritis Rheum 2009, 60(6):1588-1596.
21. Silman A., Bankhead C., Rowlingson B., et al. Do new cases of rheumatoid arthritis cluster in time or in space?. Int J Epidemiol 1997, 26(3):628-634.
22. Silman A., Harrison B., Barrett E., et al. The existence of geographical clusters of cases of inflammatory polyarthritis in a primary care based register. Ann Rheum Dis 2000, 59(2):152-154.
23. Bankhead C., Silman A., Barrett B., et al. Incidence of rheumatoid arthritis is not related to indicators of socioeconomic deprivation. JRheumatol 1996, 23(12):2039-2042.
24. Bengtsson C., Nordmark B., Klareskog L., et al. Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis 2005, 64(11):1588-1594.
25. Jacobsson L.T., Jacobsson M.E., Askling J., et al. Perinatal characteristics and risk of rheumatoid arthritis. BMJ 2003, 326(7398):1068-1069.
26. Olsson A.R., Skogh T., Wingren G. Aetiological factors of importance for the development of rheumatoid arthritis. Scand J Rheumatol 2004, 33(5):300-306.
27. Pedersen M., Jacobsen S., Klarlund M., et al. Socioeconomic status and risk of rheumatoid arthritis: a Danish case-control study. JRheumatol 2006, 33(6):1069-1074.
28. Uhlig T., Hagen K.B., Kvien T.K. Current tobacco smoking, formal education, and the risk of rheumatoid arthritis. JRheumatol 1999, 26(1):47-54.
29. Lahiri M., Luben R.N., Morgan C., et al. Using lifestyle factors to identify individuals at higher risk of inflammatory polyarthritis (results from the European Prospective Investigation of Cancer-Norfolk and the Norfolk Arthritis Register-the EPIC-2-NOAR Study). Ann Rheum Dis 2014, 73(1):219-226.
30. Koumantaki Y., Giziaki E., Linos A., et al. Family history as a risk factor for rheumatoid arthritis: a case-control study. JRheumatol 1997, 24(8):1522-1526.
31. Svendsen A.J., Holm N.V., Kyvik K., et al. Relative importance of genetic effects in rheumatoid arthritis: historical cohort study of Danish nationwide twin population. BMJ 2002, 324(7332):264-266.
32. Deighton C.M., Roberts D.F., Walker D.J. Effect of disease severity on rheumatoid arthritis concordance in same sexed siblings. Ann Rheum Dis 1992, 51(8):943-945.
33. Hemminki K., Li X., Sundquist J., et al. Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions. Arthritis Rheum 2009, 60(3):661-668.
34. Larkin J.G. Family history of rheumatoid arthritis-a non-predictor of inflammatory disease?. Rheumatology (Oxford) 2010, 49(3):608-609.
35. Jones M.A., Silman A.J., Whiting S., et al. Occurrence of rheumatoid arthritis is not increased in the first degree relatives of a population based inception cohort of inflammatory polyarthritis. Ann Rheum Dis 1996, 55(2):89-93.
36. Viatte S., Plant D., Raychaudhuri S. Genetics and epigenetics of rheumatoid arthritis. Nat Rev Rheumatol 2013, 9(3):141-153.
37. Karlson E.W., Chibnik L.B., McGrath M., et al. Aprospective study of androgen levels, hormone-related genes and risk of rheumatoid arthritis. Arthritis Res Ther 2009, 11(3):R97.
38. Colebatch A.N., Edwards C.J. The influence of early life factors on the risk of developing rheumatoid arthritis. Clin Exp Immunol 2011, 163(1):11-16.
39. Mandl L.A., Costenbader K.H., Simard J.F., et al. Is birthweight associated with risk of rheumatoid arthritis? Data from a large cohort study. Ann Rheum Dis 2009, 68(4):514-518.
40. Peschken C.A., Robinson D.B., Hitchon C.A., et al. Pregnancy and the risk of rheumatoid arthritis in a highly predisposed North American Native population. JRheumatol 2012, 39(12):2253-2260.
41. Spector T.D., Roman E., Silman A.J. The pill, parity, and rheumatoid arthritis. Arthritis Rheum 1990, 33(6):782-789.
42. Jorgensen K.T., Pedersen B.V., Jacobsen S., et al. National cohort study of reproductive risk factors for rheumatoid arthritis in Denmark: a role for hyperemesis, gestational hypertension and pre-eclampsia?. Ann Rheum Dis 2010, 69(2):358-363.
43. Karlson E.W., Mandl L.A., Hankinson S.E., et al. Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study. Arthritis Rheum 2004, 50(11):3458-3467.
44. Pikwer M., Bergstrom U., Nilsson J.A., et al. Early menopause is an independent predictor of rheumatoid arthritis. Ann Rheum Dis 2012, 71(3):378-381.
45. Berglin E., Kokkonen H., Einarsdottir E., et al. Influence of female hormonal factors, in relation to autoantibodies and genetic markers, on the development of rheumatoid arthritis in northern Sweden: a case-control study. Scand J Rheumatol 2010, 39(6):454-460.
46. Pikwer M., Bergstrom U., Nilsson J.A., et al. Breast feeding, but not use of oral contraceptives, is associated with a reduced risk of rheumatoid arthritis. Ann Rheum Dis 2009, 68(4):526-530.
47. Brennan P., Silman A. Breast-feeding and the onset of rheumatoid arthritis. Arthritis Rheum 1994, 37(6):808-813.
48. Carette S., Marcoux S., Gingras S. Postmenopausal hormones and the incidence of rheumatoid arthritis. JRheumatol 1989, 16(7):911-913.
49. Deighton C.M., Sykes H., Walker D.J. Rheumatoid arthritis, HLA identity, and age at menarche. Ann Rheum Dis 1993, 52(5):322-326.
50. Hernandez A.M., Liang M.H., Willett W.C., et al. Reproductive factors, smoking, and the risk for rheumatoid arthritis. Epidemiology 1990, 1(4):285-291.
51. Heikkila R., Aho K., Heliovaara M., et al. Serum androgen-anabolic hormones and the risk of rheumatoid arthritis. Ann Rheum Dis 1998, 57(5):281-285.
52. Pikwer M., Giwercman A., Bergstrom U., et al. Association between testosterone levels and risk of future rheumatoid arthritis in men: a population-based case-control study. Ann Rheum Dis 2014, 73(3):573-579.
53. Masi A.T., Aldag J.C., Chatterton R.T. Sex hormones and risks of rheumatoid arthritis and developmental or environmental influences. Ann N Y Acad Sci 2006, 1069:223-235.
54. Carlens C., Jacobsson L., Brandt L., et al. Perinatal characteristics, early life infections and later risk of rheumatoid arthritis and juvenile idiopathic arthritis. Ann Rheum Dis 2009, 68(7):1159-1164.
55. Rogers M.A., Levine D.A., Blumberg N., et al. Antigenic challenge in the etiology of autoimmune disease in women. JAutoimmun 2012, 38(2-3):J97-J102.
56. Ma K.K., Nelson J.L., Guthrie K.A., et al. Adverse pregnancy outcomes and risk of subsequent rheumatoid arthritis. Arthritis Rheumatol 2014, 66(3):508-512.
57. Simard J.F., Costenbader K.H., Hernan M.A., et al. Early life factors and adult-onset rheumatoid arthritis. JRheumatol 2010, 37(1):32-37.
58. Carlens C., Hergens M.P., Grunewald J., et al. Smoking, use of moist snuff, and risk of chronic inflammatory diseases. Am J Respir Crit Care Med 2010, 181(11):1217-1222.
59. Di G.D., Discacciati A., Orsini N., et al. Cigarette smoking and risk of rheumatoid arthritis: a dose-response meta-analysis. Arthritis Res Ther 2014, 16(2):R61.
60. Kallberg H., Ding B., Padyukov L., et al. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis 2011, 70(3):508-511.
61. Sugiyama D., Nishimura K., Tamaki K., et al. Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 2010, 69(1):70-81.
62. Klareskog L., Stolt P., Lundberg K., et al. Anew model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006, 54(1):38-46.
63. Jin Z., Xiang C., Cai Q., et al. Alcohol consumption as a preventive factor for developing rheumatoid arthritis: a dose-response meta-analysis of prospective studies. Ann Rheum Dis 2013, [Epub ahead of print].
64. Scott I.C., Tan R., Stahl D., et al. The protective effect of alcohol on developing rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 2013, 52(5):856-867.
65. van de Stadt L.A., van S.D. Alcohol consumption protects against arthritis development in seropositive arthralgia patients. Ann Rheum Dis 2012, 71(8):1431-1432.
66. Di G.D., Wallin A., Bottai M., et al. Long-term intake of dietary long-chain n-3 polyunsaturated fatty acids and risk of rheumatoid arthritis: a prospective cohort study of women. Ann Rheum Dis 2013, [Epub ahead of print].
67. Linos A., Kaklamanis E., Kontomerkos A., et al. The effect of olive oil and fish consumption on rheumatoid arthritis-a case control study. Scand J Rheumatol 1991, 20(6):419-426.
68. Linos A., Kaklamani V.G., Kaklamani E., et al. Dietary factors in relation to rheumatoid arthritis: a role for olive oil and cooked vegetables?. Am J Clin Nutr 1999, 70(6):1077-1082.
69. Oliver J.E., Silman A.J. Risk factors for the development of rheumatoid arthritis. Scand J Rheumatol 2006, 35(3):169-174.
70. Pattison D.J., Harrison R.A., Symmons D.P. The role of diet in susceptibility to rheumatoid arthritis: a systematic review. JRheumatol 2004, 31(7):1310-1319.
71. Pedersen M., Stripp C., Klarlund M., et al. Diet and risk of rheumatoid arthritis in a prospective cohort. JRheumatol 2005, 32(7):1249-1252.
72. Rosell M., Wesley A.M., Rydin K., et al. Dietary fish and fish oil and the risk of rheumatoid arthritis. Epidemiology 2009, 20(6):896-901.
73. Shapiro J.A., Koepsell T.D., Voigt L.F., et al. Diet and rheumatoid arthritis in women: a possible protective effect of fish consumption. Epidemiology 1996, 7(3):256-263.
74. Song G.G., Bae S.C., Lee Y.H. Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis. Clin Rheumatol 2012, 31(12):1733-1739.
75. Nielen M.M., van S.D., Lems W.F., et al. Vitamin D deficiency does not increase the risk of rheumatoid arthritis: comment on the article by Merlino, etal. Arthritis Rheum 2006, 54(11):3719-3720.
76. Feser M., Derber L.A., Deane K.D., et al. Plasma 25,OH vitamin D concentrations are not associated with rheumatoid arthritis (RA)-related autoantibodies in individuals at elevated risk for RA. JRheumatol 2009, 36(5):943-946.
77. Hiraki L.T., Munger K.L., Costenbader K.H., et al. Dietary intake of vitamin D during adolescence and risk of adult-onset systemic lupus erythematosus and rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012, 64(12):1829-1836.
78. Arkema E.V., Hart J.E., Bertrand K.A., et al. Exposure to ultraviolet-B and risk of developing rheumatoid arthritis among women in the Nurses' Health Study. Ann Rheum Dis 2013, 72(4):506-511.
79. Cerhan J.R., Saag K.G., Merlino L.A., et al. Antioxidant micronutrients and risk of rheumatoid arthritis in a cohort of older women. Am J Epidemiol 2003, 157(4):345-354.
80. Comstock G.W., Burke A.E., Hoffman S.C., et al. Serum concentrations of alpha tocopherol, beta carotene, and retinol preceding the diagnosis of rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 1997, 56(5):323-325.
81. Heliovaara M., Knekt P., Aho K., et al. Serum antioxidants and risk of rheumatoid arthritis. Ann Rheum Dis 1994, 53(1):51-53.
82. Knekt P., Heliovaara M., Aho K., et al. Serum selenium, serum alpha-tocopherol, and the risk of rheumatoid arthritis. Epidemiology 2000, 11(4):402-405.
83. Pattison D.J., Silman A.J., Goodson N.J., et al. Vitamin C and the risk of developing inflammatory polyarthritis: prospective nested case-control study. Ann Rheum Dis 2004, 63(7):843-847.
84. Costenbader K.H., Kang J.H., Karlson E.W. Antioxidant intake and risks of rheumatoid arthritis and systemic lupus erythematosus in women. Am J Epidemiol 2010, 172(2):205-216.
85. Pattison D.J., Symmons D.P., Lunt M., et al. Dietary beta-cryptoxanthin and inflammatory polyarthritis: results from a population-based prospective study. Am J Clin Nutr 2005, 82(2):451-455.
86. Afridi H.I., Kazi T.G., Brabazon D., et al. Association between essential trace and toxic elements in scalp hair samples of smokers rheumatoid arthritis subjects. Sci Total Environ 2011, 412-413:93-100.
87. Afridi H.I., Kazi T.G., Brabazon D., et al. Interaction between zinc, cadmium, and lead in scalp hair samples of Pakistani and Irish smokers rheumatoid arthritis subjects in relation to controls. Biol Trace Elem Res 2012, 148(2):139-147.
88. Bergstrom U., Jacobsson L.T., Nilsson J.A., et al. Pulmonary dysfunction, smoking, socioeconomic status and the risk of developing rheumatoid arthritis. Rheumatology (Oxford) 2011, 50(11):2005-2013.
89. Cooper G.S., Miller F.W., Germolec D.R. Occupational exposures and autoimmune diseases. Int Immunopharmacol 2002, 2(2-3):303-313.
90. Khuder S.A., Peshimam A.Z., Agraharam S. Environmental risk factors for rheumatoid arthritis. Rev Environ Health 2002, 17(4):307-315.
91. Olsson A.R., Skogh T., Wingren G. Occupational determinants for rheumatoid arthritis. Scand J Work Environ Health 2000, 26(3):243-249.
92. Turner S., Cherry N. Rheumatoid arthritis in workers exposed to silica in the pottery industry. Occup Environ Med 2000, 57(7):443-447.
93. Stolt P., Yahya A., Bengtsson C., et al. Silica exposure among male current smokers is associated with a high risk of developing ACPA-positive rheumatoid arthritis. Ann Rheum Dis 2010, 69(6):1072-1076.
94. De Roos A.J., Cooper G.S., Alavanja M.C., et al. Rheumatoid arthritis among women in the Agricultural Health Study: risk associated with farming activities and exposures. Ann Epidemiol 2005, 15(10):762-770.
95. Olsson A.R., Skogh T., Axelson O., et al. Occupations and exposures in the work environment as determinants for rheumatoid arthritis. Occup Environ Med 2004, 61(3):233-238.
96. Sverdrup B., Kallberg H., Bengtsson C., et al. Association between occupational exposure to mineral oil and rheumatoid arthritis: results from the Swedish EIRA case-control study. Arthritis Res Ther 2005, 7(6):R1296-R1303.
97. Stolt P., Kallberg H., Lundberg I., et al. Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis 2005, 64(4):582-586.
98. Gan R.W., Deane K.D., Zerbe G.O., et al. Relationship between air pollution and positivity of RA-related autoantibodies in individuals without established RA: a report on SERA. Ann Rheum Dis 2013, 72(12):2002-2005.
99. Hart J.E., Kallberg H., Laden F., et al. Ambient air pollution exposures and risk of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2013, 65(7):1190-1196.
100. Hart J.E., Kallberg H., Laden F., et al. Ambient air pollution exposures and risk of rheumatoid arthritis: results from the Swedish EIRA case-control study. Ann Rheum Dis 2013, 72(6):888-894.
101. Ray P., Black S., Shinefield H., et al. Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15-59 years of age. Vaccine 2011, 29(38):6592-6597.
102. Blaschke S., Schwarz G., Moneke D., et al. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis. JRheumatol 2000, 27(4):866-873.
103. Buskila D., Shnaider A., Neumann L., et al. Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients. Semin Arthritis Rheum 1998, 28(2):107-113.
104. Sawada T., Hirohata S., Inoue T., et al. Development of rheumatoid arthritis after hepatitis C virus infection. Arthritis Rheum 1991, 34(12):1620-1621.
105. Medina-Rodriguez F., Guzman C., Jara L.J., et al. Rheumatic manifestations in human immunodeficiency virus positive and negative individuals: a study of 2 populations with similar risk factors. JRheumatol 1993, 20(11):1880-1884.
106. Saebo A., Lassen J. Yersinia enterocolitica: an inducer of chronic inflammation. Int J Tissue React 1994, 16(2):51-57.
107. Schaeverbeke T., Vernhes J.P., Lequen L., et al. Mycoplasmas and arthritides. Rev Rhum Engl Ed 1997, 64(2):120-128.
108. Hitchon C.A., Chandad F., Ferucci E.D., et al. Antibodies to Porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives. JRheumatol 2010, 37(6):1105-1112.
109. Mikuls T.R., Thiele G.M., Deane K.D., et al. Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis. Arthritis Rheum 2012, 64(11):3522-3530.
110. Bengtsson C., Kapetanovic M.C., Kallberg H., et al. Common vaccinations among adults do not increase the risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis 2010, 69(10):1831-1833.
111. Cohen A.D., Shoenfeld Y. Vaccine-induced autoimmunity. JAutoimmun 1996, 9(6):699-703.
112. Schattner A. Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine 2005, 23(30):3876-3886.
113. Shoenfeld Y., Aron-Maor A. Vaccination and autoimmunity-'vaccinosis': a dangerous liaison?. JAutoimmun 2000, 14(1):1-10.
114. Symmons D.P., Chakravarty K. Can immunisation trigger rheumatoid arthritis?. Ann Rheum Dis 1993, 52(12):843-844.
115. Boyer J.F., Gourraud P.A., Cantagrel A., et al. Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis. Joint Bone Spine 2011, 78(2):179-183.
116. Reynisdottir G., Karimi R., Joshua V., et al. Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis. Arthritis Rheumatol 2014, 66(1):31-39.
117. Verstappen S.M., Lunt M., Luben R.N., et al. Demographic and disease-related predictors of abnormal lung function in patients with established inflammatory polyarthritis and a comparison with the general population. Ann Rheum Dis 2013, 72(9):1517-1523.
118. Demoruelle M.K., Weisman M.H., Simonian P.L., et al. Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity?. Arthritis Rheum 2012, 64(6):1756-1761.
119. Oken R.J., Schulzer M. At issue: schizophrenia and rheumatoid arthritis: the negative association revisited. Schizophr Bull 1999, 25(4):625-638.
120. Crowson C.S., Matteson E.L., Davis J.M., et al. Contribution of obesity to the rise in incidence of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2013, 65(1):71-77.
121. de Hair M.J., Landewe R.B., van de Sande M.G., et al. Smoking and overweight determine the likelihood of developing rheumatoid arthritis. Ann Rheum Dis 2013, 72(10):1654-1658.
122. Symmons D.P., Bankhead C.R., Harrison B.J., et al. Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England. Arthritis Rheum 1997, 40(11):1955-1961.
123. Wesley A., Bengtsson C., Elkan A.C., et al. Association between body mass index and anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis: results from a population-based case-control study. Arthritis Care Res (Hoboken) 2013, 65(1):107-112.
124. Kang J.H., Lin H.C. Obstructive sleep apnea and the risk of autoimmune diseases: a longitudinal population-based study. Sleep Med 2012, 13(6):583-588.
125. Maki-Petaja K.M., Booth A.D., Hall F.C., et al. Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis. JAm Coll Cardiol 2007, 50(9):852-858.
126. Steiner G., Urowitz M.B. Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment. Semin Arthritis Rheum 2009, 38(5):372-381.
127. van de Stadt L.A., van Sijl A.M., van S.D., et al. Dyslipidaemia in patients with seropositive arthralgia predicts the development of arthritis. Ann Rheum Dis 2012, 71(11):1915-1916.
128. van Halm V.P., Nielen M.M., Nurmohamed M.T., et al. Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann Rheum Dis 2007, 66(2):184-188.
129. Myasoedova E., Crowson C.S., Kremers H.M., et al. Total cholesterol and LDL levels decrease before rheumatoid arthritis. Ann Rheum Dis 2010, 69(7):1310-1314.
130. Dobson R., Giovannoni G. Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis. JNeurol 2013, 260(5):1272-1285.
131. Avouac J., Gossec L., Dougados M. Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 2006, 65(7):845-851.
132. Berglin E., Padyukov L., Sundin U., et al. Acombination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res Ther 2004, 6(4):R303-R308.
133. Brink M., Hansson M., Mathsson L., et al. Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis. Arthritis Rheum 2013, 65(4):899-910.
134. Dorner T., Hansen A. Autoantibodies in normals-the value of predicting rheumatoid arthritis. Arthritis Res Ther 2004, 6(6):282-284.
135. Kokkonen H., Mullazehi M., Berglin E., et al. Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis. Arthritis Res Ther 2011, 13(1):R13.
136. Majka D.S., Holers V.M. Can we accurately predict the development of rheumatoid arthritis in the preclinical phase?. Arthritis Rheum 2003, 48(10):2701-2705.
137. Nielen M.M., van S.D., Reesink H.W., et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004, 50(2):380-386.
138. Rantapaa-Dahlqvist S., de Jong B.A., Berglin E., et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003, 48(10):2741-2749.
139. Saraux A., Berthelot J.M., Chales G., et al. Value of laboratory tests in early prediction of rheumatoid arthritis. Arthritis Rheum 2002, 47(2):155-165.
140. Scofield R.H. Autoantibodies as predictors of disease. Lancet 2004, 363(9420):1544-1546.
141. Koivula M.K., Heliovaara M., Rissanen H., et al. Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis. Ann Rheum Dis 2012, 71(10):1666-1670.
142. Nielsen S.F., Bojesen S.E., Schnohr P., et al. Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study. BMJ 2012, 345:e5244.
143. van de Stadt L.A., van der Horst A.R., de Koning M.H., et al. The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia. Ann Rheum Dis 2011, 70(1):128-133.
144. Bos W.H., Wolbink G.J., Boers M., et al. Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study. Ann Rheum Dis 2010, 69(3):490-494.
145. van de Stadt L.A., Witte B.I., Bos W.H., et al. Aprediction rule for the development of arthritis in seropositive arthralgia patients. Ann Rheum Dis 2013, 72(12):1920-1926.
146. Shi J., van de Stadt L.A., Levarht E.W., et al. Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis. Arthritis Rheum 2013, 65(4):911-915.
147. Kolfenbach J.R., Deane K.D., Derber L.A., et al. Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis. Arthritis Rheum 2010, 62(9):2633-2639.
148. Aho K., Palosuo T., Knekt P., et al. Serum C-reactive protein does not predict rheumatoid arthritis. JRheumatol 2000, 27(5):1136-1138.
149. Barra L., Summers K., Bell D., et al. Serum cytokine profile of unaffected first-degree relatives of patients with rheumatoid arthritis. JRheumatol 2014, 41(2):280-285.
150. Deane K.D., O'Donnell C.I., Hueber W., et al. The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner. Arthritis Rheum 2010, 62(11):3161-3172.
151. Edwards C.J., Cooper C. Early environmental factors and rheumatoid arthritis. Clin Exp Immunol 2006, 143(1):1-5.
152. El-Gabalawy H.S., Robinson D.B., Smolik I., et al. Familial clustering of the serum cytokine profile in the relatives of rheumatoid arthritis patients. Arthritis Rheum 2012, 64(6):1720-1729.
153. Hughes-Austin J.M., Deane K.D., Derber L.A., et al. Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: studies of the Aetiology of Rheumatoid Arthritis (SERA). Ann Rheum Dis 2013, 72(6):901-907.
154. Jorgensen K.T., Wiik A., Pedersen M., et al. Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors. Ann Rheum Dis 2008, 67(6):860-866.
155. Karlson E.W., Chibnik L.B., Tworoger S.S., et al. Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies. Arthritis Rheum 2009, 60(3):641-652.
156. Limper M., van de Stadt L., Bos W., et al. The acute-phase response is not predictive for the development of arthritis in seropositive arthralgia - a prospective cohort study. JRheumatol 2012, 39(10):1914-1917.
157. Masi A.T., Aldag J.C., Sipes J. Do elevated levels of serum C-reactive protein predict rheumatoid arthritis in men: correlations with pre-RA status and baseline positive rheumatoid factors. JRheumatol 2001, 28(10):2359-2361.
158. Nielen M.M., van S.D., Reesink H.W., et al. Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis. Arthritis Rheum 2004, 50(8):2423-2427.
159. Rantapaa-Dahlqvist S., Boman K., Tarkowski A., et al. Up regulation of monocyte chemoattractant protein-1 expression in anti-citrulline antibody and immunoglobulin M rheumatoid factor positive subjects precedes onset of inflammatory response and development of overt rheumatoid arthritis. Ann Rheum Dis 2007, 66(1):121-123.
160. Sokolove J., Bromberg R., Deane K.D., et al. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS One 2012, 7(5):e35296.
161. Turesson C., Bergstrom U., Jacobsson L.T., et al. Increased cartilage turnover and circulating autoantibodies in different subsets before the clinical onset of rheumatoid arthritis. Ann Rheum Dis 2011, 70(3):520-522.
162. Woolf A.D., Hall N.D., Goulding N.J., et al. Predictors of the long-term outcome of early synovitis: a 5-year follow-up study. Br J Rheumatol 1991, 30(4):251-254.
163. van Baarsen L.G., Wijbrandts C.A., Timmer T.C., et al. Synovial tissue heterogeneity in rheumatoid arthritis in relation to disease activity and biomarkers in peripheral blood. Arthritis Rheum 2010, 62(6):1602-1607.
164. Lubbers J., Brink M., van de Stadt L.A., et al. The type I IFN signature as a biomarker of preclinical rheumatoid arthritis. Ann Rheum Dis 2013, 72(5):776-780.
165. van de Stadt L.A., Bos W.H., Meursinge R.M., et al. The value of ultrasonography in predicting arthritis in auto-antibody positive arthralgia patients: a prospective cohort study. Arthritis Res Ther 2010, 12(3):R98.
166. Rakieh C., Nam J.L., Hunt L., et al. Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study. Ann Rheum Dis 2014, [Epub ahead of print].
167. de Bois M.H., Arndt J.W., Speyer I., et al. Technetium-99m labelled human immunoglobulin scintigraphy predicts rheumatoid arthritis in patients with arthralgia. Scand J Rheumatol 1996, 25(3):155-158.
168. Shearman J., Esdaile J., Hawkins D., et al. Predictive value of radionuclide joint scintigrams. Arthritis Rheum 1982, 25(1):83-86.
169. Gent Y.Y., Voskuyl A.E., Kloet R.W., et al. Macrophage positron emission tomography imaging as a biomarker for preclinical rheumatoid arthritis: findings of a prospective pilot study. Arthritis Rheum 2012, 64(1):62-66.
170. van Steenbergen H.W., van Nies J.A., Huizinga T.W., et al. Characterising arthralgia in the preclinical phase of rheumatoid arthritis using MRI. Ann Rheum Dis 2014, [Epub ahead of print].
171. van Steenbergen H.W., van Nies J.A., Huizinga T.W., et al. Subclinical inflammation on MRI of hand and foot of anti-citrullinated peptide antibody-negative arthralgia patients at risk for rheumatoid arthritis. Arthritis Res Ther 2014, 16(2):R92.
172. Sparks J.A., Chen C.Y., Jiang X., et al. Improved performance of epidemiologic and genetic risk models for rheumatoid arthritis serologic phenotypes using family history. Ann Rheum Dis 2014, [Epub ahead of print].
173. Young K.A., Deane K.D., Derber L.A., et al. Relatives without rheumatoid arthritis show reactivity to anti-citrullinated protein/peptide antibodies that are associated with arthritis-related traits: studies of the etiology of rheumatoid arthritis. Arthritis Rheum 2013, 65(8):1995-2004.
174. Karlson E.W., Ding B., Keenan B.T., et al. Association of environmental and genetic factors and gene-environment interactions with risk of developing rheumatoid arthritis. Arthritis Care Res (Hoboken) 2013, 65(7):1147-1156.
175. Bos W.H., Dijkmans B.A., Boers M., et al. Effect of dexamethasone on autoantibody levels and arthritis development in patients with arthralgia: a randomised trial. Ann Rheum Dis 2010, 69(3):571-574.
176. Karlson E.W., Shadick N.A., Cook N.R., et al. Vitamin E in the primary prevention of rheumatoid arthritis: the Women's Health Study. Arthritis Rheum 2008, 59(11):1589-1595.
177. del P.A., Knowler W.C., Pettitt D.J., et al. The incidence of rheumatoid arthritis is predicted by rheumatoid factor titer in a longitudinal population study. Arthritis Rheum 1988, 31(10):1239-1244.
178. Peschken C.A., Hitchon C.A., Robinson D.B., et al. Rheumatoid arthritis in a North American native population: longitudinal followup and comparison with a white population. JRheumatol 2010, 37(8):1589-1595.
179. Stack R.J., Sahni M., Mallen C.D., et al. Symptom complexes at the earliest phases of rheumatoid arthritis: a synthesis of the qualitative literature. Arthritis Care Res (Hoboken) 2013, 65(12):1916-1926.
180. Available at: . Accessed on June 20, 2014. http://www.trialregister.nl/trialreg/admin/rctsearch.asp?Term=prairi.